Insider Transactions in Q1 2024 at Viracta Therapeutics, Inc. (VIRX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2024
|
Daniel R. Chevallard CFO and COO |
SELL
Open market or private sale
|
Direct |
3,405
-3.22%
|
$0
$0.73 P/Share
|
|
Feb 25
2024
|
Roger Pomerantz |
BUY
Exercise of conversion of derivative security
|
Direct |
9,034
+8.33%
|
-
|
|
Feb 25
2024
|
Ivor Royston |
BUY
Exercise of conversion of derivative security
|
Direct |
25,219
+3.2%
|
-
|
|
Feb 25
2024
|
Daniel R. Chevallard CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,889
+6.12%
|
-
|